Effects of a non-steroidal anti-inflammatory drug on delayed onset muscle soreness and indices of damage

Gespeichert in:
Bibliographische Detailangaben
Deutscher übersetzter Titel:Auswirkungen eines nichtsteroiden entzuendungshemmenden Medikaments auf Muskelkater und Muskelfaserschaden
Autor:Donnelly, A.E.; McCormick, K.; Maughan, R.J.; Whiting, P.H.; Clarkson, P.M.
Erschienen in:British journal of sports medicine
Veröffentlicht:22 (1988), 1, S. 35-38, Lit.
Format: Literatur (SPOLIT)
Publikationstyp: Zeitschriftenartikel
Medienart: Gedruckte Ressource
Sprache:Englisch
ISSN:0306-3674, 1473-0480
Schlagworte:
Online Zugang:
Erfassungsnummer:PU198807008126
Quelle:BISp

Abstract

Twenty untrained male volunteers were required to run downhill for 45 minutes on a motor driven treadmill to induce muscle soreness. The volunteers took diclofenac or placebo before and for 72 hours after two runs 10 weeks apart, in a randomised double blind crossow design. Subjective soreness was assessed before and at intervals up to 72 hours after each run; venous blood samples, collected at the same time intervals, were used to estimate serum activities of creatine kinase, lactate dehydrygonase and aspartate aminotransferase and serum concentrations of creatinine and urea. Subjective soreness and the biochemical parameters increased after both runs, although their serum enzyme response to the second run was reduced. Diclofenac had no influence on the serum biochemical response to downhill running. Although overall soreness was not affected by diclofenac, individual soreness measurements were reduced by diclofenac at the first period of the study. These results suggest that diclofenac does not influence muscle damage, but may slightly reduce the associated soreness. Verf.-Referat